JiangXi Tianxin Pharmaceutical Co Ltd. Stock Analysis 603235.SS

JiangXi Tianxin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of monomeric vitamins. The company is headquartered in Jingdezhen, Jiangxi and currently employs 2,893 full-time employees. The company went IPO on 2022-07-12. The firm's business encompasses B vitamins, other vitamins, and fine chemicals. The firm's main products include vitamin B6, vitamin B1, biotin, folic acid, vitamin B5, vitamin D3, ascorbyl palmitate, vitamin E powder, vitamin A and other products. The firm's fine chemicals mainly include alpha-acetyl-gamma-butyrolactone (ABL), cholesterol, sodium methoxide, and L-alanine. The firm's products are mainly used in the fields of feed, medicine and food. The firm mainly conducts its businesses in domestic and overseas markets.